NYSE - Nasdaq Real Time Price USD

Qiagen N.V. (QGEN)

41.49

+0.34

+(0.83%)

As of 10:20:34 AM EDT. Market Open.

Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings

The market for Qiagen N.V.'s ( NYSE:QGEN ) shares didn't move much after it posted weak earnings recently. Our analysis...

Simply Wall St. 3 hours ago

QGEN
+0.83%
Qiagen First Quarter 2025 Earnings: Beats Expectations

Qiagen ( NYSE:QGEN ) First Quarter 2025 Results Key Financial Results Revenue: US$483.5m (up 5.4% from 1Q 2024). Net...

Simply Wall St. yesterday

QGEN
+0.83%
QIAGEN Stock Gains Following the Acquisition of Genoox

QGEN inks an agreement to acquire Genoox for $70 million in cash. The acquisition expands QIAGEN's QDI portfolio.

Zacks 2 days ago

QGEN
+0.83%
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

VENLO, the Netherlands & TEL AVIV, Israel, May 12, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.

Business Wire 2 days ago

QGEN
+0.83%
The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Last week, you might have seen that Qiagen N.V. ( NYSE:QGEN ) released its first-quarter result to the market. The...

Simply Wall St. 4 days ago

QGEN
+0.83%
QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

QGEN's quarterly performance benefits from a resilient portfolio in the first quarter of 2025.

Zacks 7 days ago

QGEN
+0.83%
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 7 days ago

QGEN
+0.83%
Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

Qiagen (QGEN) delivered earnings and revenue surprises of 10% and 4.18%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 7 days ago

QGEN
+0.83%
Qiagen: Q1 Earnings Snapshot

PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported first-quarter profit of $90.8 million. On a per-share basis, the Pl Venlo, Netherlands-based company said it had net income of 41 cents. Earnings, adjusted for non-recurring costs, came to 55 cents per share.

Associated Press Finance 7 days ago

QGEN
+0.83%
QIAGEN announces plans for transition in leadership of Supervisory Board

VENLO, the Netherlands, May 07, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board intends to elect Stephen H. Rusckowski to succeed Lawrence A. Rosen as Chairman of the Supervisory Board following its Annual General Meeting on June 26, 2025.

Business Wire 7 days ago

QGEN
+0.83%
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

VENLO, the Netherlands, May 07, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today confirmed strong Q1 2025 results in line with the preliminary announcement and reaffirmed its FY 2025 outlook based on the solid start to the year and evolving macroeconomic trends.

Business Wire 7 days ago

QGEN
+0.83%
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

VENLO, the Netherlands, May 07, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board will propose the initiation of an annual cash dividend under an amended dividend policy to QIAGEN’s shareholders at the next Annual General Meeting scheduled for June 26, 2025.

Business Wire 8 days ago

QGEN
+0.83%
Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Qiagen (QGEN) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks 9 days ago

QGEN
+0.83%
QGEN or RGEN: Which Is the Better Value Stock Right Now?

QGEN vs. RGEN: Which Stock Is the Better Value Option?

Zacks 12 days ago

RGEN

QGEN
+0.83%
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 28.57% and 21.53%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 13 days ago

ADPT

QGEN
+0.83%
Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Sangamo (SGMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 14 days ago

SGMO

QGEN
+0.83%
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 15 days ago

QGEN
+0.83%

ARQT
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

VENLO, the Netherlands, April 29, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that now includes solutions for lentivirus-based applications, commonly used in the production of advanced treatments such as chimeric antigen receptor T-cell (CAR-T), a personalized form of cancer immunotherapy.

Business Wire 15 days ago

QGEN
+0.83%
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 16 days ago

QGEN
+0.83%
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

VENLO, Netherlands, April 22, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling.

Business Wire 22 days ago

QGEN
+0.83%

Performance Overview

Return	QGEN	S&P 500 (^GSPC)
YTD	-6.83%	-0.04%
1-Year	-9.35%	+10.76%
3-Year	-7.26%	+46.10%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Qiagen N.V. (QGEN)

Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings

Qiagen First Quarter 2025 Earnings: Beats Expectations

QIAGEN Stock Gains Following the Acquisition of Genoox

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

Qiagen: Q1 Earnings Snapshot

QIAGEN announces plans for transition in leadership of Supervisory Board

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Performance Overview